ThermoGenesis (THMO -0.2%) entered into a supply agreement with BioHit Healthcare to market, ThermoGenesis branded SARS-CoV-2 IgM/IgG Antibody Test Kit, which has already received FDA Emergency Use Authorization (EUA).
The Company simultaneously withdrew its own EUA submission for the previously announced SARS-CoV-2 antibody Fast Detection Kit (Colloidal Gold).
The new branded antibody test kit is expected to initiate marketing from Monday.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.